7XSR image
Deposition Date 2022-05-15
Release Date 2022-11-09
Last Version Date 2024-07-03
Entry Detail
PDB ID:
7XSR
Title:
Structure of Craspase-target RNA
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.97 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polyribonucleotide
Molecule:RNA (5'-R(P*GP*GP*GP*GP*CP*AP*GP*AP*AP*AP*AP*UP*UP*GP*G)-3')
Chain IDs:C (auth: A)
Chain Length:38
Number of Molecules:1
Biological Source:Candidatus Scalindua brodae
Polymer Type:polypeptide(L)
Molecule:RAMP superfamily protein
Gene (Uniprot):SCABRO_02597
Chain IDs:A (auth: B)
Chain Length:1722
Number of Molecules:1
Biological Source:Candidatus Scalindua brodae
Polymer Type:polypeptide(L)
Molecule:CHAT domain protein
Gene (Uniprot):SCABRO_02601
Chain IDs:B (auth: C)
Chain Length:716
Number of Molecules:1
Biological Source:Candidatus Scalindua brodae
Polymer Type:polyribonucleotide
Molecule:RNA (34-MER)
Chain IDs:D
Chain Length:74
Number of Molecules:1
Biological Source:Candidatus Scalindua brodae
Ligand Molecules
Primary Citation
Target RNA activates the protease activity of Craspase to confer antiviral defense.
Mol.Cell 82 4503 4518.e8 (2022)
PMID: 36306795 DOI: 10.1016/j.molcel.2022.10.007

Abstact

In the type III-E CRISPR-Cas system, a Cas effector (gRAMP) is associated with a TPR-CHAT to form Craspase (CRISPR-guided caspase). However, both the structural features of gRAMP and the immunity mechanism remain unknown for this system. Here, we report structures of gRAMP-crRNA and gRAMP:cRNA:target RNA as well as structures of Craspase and Craspase complexed with cognate target RNA (CTR) or non-cognate target RNA (NTR). Importantly, the 3' anti-tag region of NTR and CTR binds at two distinct channels in Craspase, and CTR with a non-complementary 3' anti-tag induces a marked conformational change of the TPR-CHAT, which allosterically activates its protease activity to cleave an ancillary protein Csx30. This cleavage then triggers an abortive infection as the antiviral strategy of the type III-E system. Together, our study provides crucial insights into both the catalytic mechanism of the gRAMP and the immunity mechanism of the type III-E system.

Legend

Protein

Chemical

Disease

Primary Citation of related structures